Why is the CSL share price sliding lower on Monday?

Investors should be stoked with CSL's share price drop today.

| More on:
woman testing substance in laboratory dish, csl share price

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's been a rough start to the week for the S&P/ASX 200 Index (ASX: XJO) and ASX shares. At the time of writing, the ASX 200 has opened 0.14% lower so far this Monday. But let's talk about the CSL Limited (ASX: CSL) share price. 

If you thought the ASX 200's start to the week was disappointing, wait until you see what's going on with CSL shares. The ASX 200 healthcare stock closed last week at a share price of $270.85. But this morning, CSL opened at $269 a share and is currently going for just $266.65 at the time of writing, down a nasty 1.55% for the day so far.

Before any CSL investors get carried away with wondering what's going wrong with their investment today, it's worth pointing out that there's a good reason for CSL's rather steep drop this Monday. This healthcare share has just traded ex-dividend for its upcoming shareholder payment.

CSL share price stutters as company trades ex-dividend

Last month, we analysed CSL's latest earnings report, covering the full 2023 financial year. It was a well-received earnings report at the time, with the healthcare giant revealing that it had managed to grow revenues by a healthy 31% in constant currency terms to US$13.31 billion.

Net profits after tax before amortisation rose by 20% in constant currency to US$2.86 billion, while reported net profits lifted by 10% to US$2.61 billion.

That enabled CSL to boost its final dividend for 2023 by 9.3% to US$1.29 per share, partially franked at 10%. That's the largest dividend CSL has ever paid out. This payment takes the company's full-year dividends to US$2.36 per share, up 6% from last year.

However, as we warned last week, CSL's ex-dividend date for this supersized shareholder payment is today. This means that anyone buying CSL shares from today onwards is not eligible to receive this latest dividend.

That's why we are seeing such a dramatic fall in the CSL share price this Monday relative to the ASX 200. It usually happens when an ASX share trades ex-dividend, and reflects this inherent loss of value for new investors going forward.

So existing CSL investors have nothing to complain about with their company seeing a share price drop today. It's the best reason to see a company have a red day on the markets.

CSL shareholders can now look forward to receiving their latest dividend next month on 4 October.

Right now, CSL shares have a dividend yield of 1.15%. The CSL share price remains down by 5.5% in 2023 to date, as well as by 10.1% over the past 12 months, as you can see below:

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A woman jumps for joy with a rocket drawn on the wall behind her.
Healthcare Shares

Guess which ASX healthcare stock is jumping 7% on US FDA approval news

This share is giving its shareholders an early Christmas present.

Read more »

A senior pharmacist talks to a customer at the counter in a shop
Healthcare Shares

Is it too late to buy Sigma shares to cash in on the Chemist Warehouse deal?

Can investors still make healthy returns with this stock?

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Why the Mesoblast share price is diving 18% after an FDA win

Investors are sending the Mesoblast share price tumbling on Friday. But why?

Read more »

A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition
Healthcare Shares

Mesoblast share price rockets 30% on big US FDA news

Big news is giving this biotech a huge lift on Thursday.

Read more »

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

Guess which ASX healthcare stock is jumping 12% on Wednesday

This shares is rocketing this morning. But why? Let's find out.

Read more »

Man holding out Australian dollar notes, symbolising dividends.
Healthcare Shares

Here is the dividend forecast to 2029 for CSL shares

Can this blue-chip giant provide healthy dividend income?

Read more »

a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
Healthcare Shares

The best ASX 200 healthcare stocks to buy in 2025

These shares could give your portfolio a healthy boost next year according to Bell Potter.

Read more »

In the lab at work, the mature adult woman and young adult man smile as they review the results of their successful experimentation.
Healthcare Shares

ASX 300 healthcare stock lifts off on promising new results

Up 28% in a year, the ASX healthcare stock is leaping higher on Thursday.

Read more »